Skip to main content

Table 2 Rb1, P16 and ER protein expression in ovarian epithelial carcinoma cases studied according to clinico-pathologic variables (n = 130)

From: Comparative analysis of Rb1, P16 and ER as diagnostic, prognostic and potential targets for therapeutic agents in ovarian epithelial tumors: an immunohistochemical study of 130 ovarian carcinomas

IHC expression

Tumor size (pT)

Tumor grade

T1 (n = 51)

T2 (n = 53)

T3 (n = 19)

G1 (n = 28)

G2 (n = 29)

G3 (n = 73)

G1/2 (n = 57)

Rb1+ (n = 70)

24

33

9

19

19

32

38

P16+ (n = 71)

27

27

13

7

11

53

18

ER+ (n = 57)

23

24

9

10

9

38

19

Rb1+/P16+ (n = 30)

9

11

8

3

5

19

8

Rb1+/P16- (n = 40)

18

24

1

10

16

14

26

Rb1-/P16+ (n = 41)

19

16

5

2

6

33

8

Rb1+/ER- (n = 46)

14

23

6

12

15

19

27

Rb1+/ER+ (n = 24)

10

10

3

7

4

13

11

Rb1+/P16+/ER+ (n = 10)

4

2

3

2

1

7

3

Rb1-/P16-/ER- (n = 12)

8

2

1

6

2

4

8

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us